Dune Medical Technologies, accessible at dunemedical.com, is a forward-thinking company specializing in advanced medical technologies designed to improve surgical outcomes and patient care. The company operates primarily in the healthcare sector, focusing on innovative solutions that assist surgeons and medical professionals in achieving better results during procedures.

Dune Medical's flagship product, MarginProbe, is a groundbreaking device that helps surgeons determine if they have successfully removed all cancerous tissue during a lumpectomy, a surgery to remove breast cancer. This device provides real-time feedback in the operating room, reducing the need for additional surgeries and improving patient outcomes. The company also offers the Navigator, a sterilizable probe that helps in infection control, and the CoPilot VL, a portable video laryngoscope system that aids in intubation, making it safer and more efficient.

The primary clients of Dune Medical Technologies are hospitals, surgical centers, and healthcare providers who perform breast cancer surgeries and other critical procedures. The company operates in the global healthcare market, addressing the needs of medical professionals worldwide.

Dune Medical's business model revolves around the development, manufacturing, and distribution of its medical devices. The company generates revenue through the sale of these devices to healthcare institutions and professionals. Additionally, they may offer training and support services to ensure the effective use of their products.

In summary, Dune Medical Technologies is dedicated to enhancing surgical precision and patient care through its innovative medical devices. By focusing on real-time solutions that improve surgical outcomes, the company plays a crucial role in the healthcare industry.

Keywords: medical technology, surgical devices, cancer surgery, MarginProbe, Navigator, CoPilot VL, healthcare, infection control, breast cancer, patient care.